OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interaction of human papillomaviruses with the host immune system: A well evolved relationship
Ian H. Frazer
Virology (2008) Vol. 384, Iss. 2, pp. 410-414
Closed Access | Times Cited: 202

Showing 1-25 of 202 citing articles:

Human Papillomavirus and Cervical Cancer
Eileen M. Burd
Clinical Microbiology Reviews (2003) Vol. 16, Iss. 1, pp. 1-17
Open Access | Times Cited: 2138

DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway
Laura Lau, Elizabeth Gray, Rebecca Brunette, et al.
Science (2015) Vol. 350, Iss. 6260, pp. 568-571
Closed Access | Times Cited: 405

Persistence of human papillomavirus infection: keys to malignant progression
Jason M. Bodily, Laimonis A. Laimins
Trends in Microbiology (2010) Vol. 19, Iss. 1, pp. 33-39
Open Access | Times Cited: 305

The role of inflammation in HPV carcinogenesis
Enrique Boccardo, Ana Paula Lepique, Luisa L. Villa
Carcinogenesis (2010) Vol. 31, Iss. 11, pp. 1905-1912
Open Access | Times Cited: 186

Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer
Rabia Faridi, Amreen Zahra, Khalida Khan, et al.
Virology Journal (2011) Vol. 8, Iss. 1
Open Access | Times Cited: 173

Human Papillomavirus (HPV) Upregulates the Cellular Deubiquitinase UCHL1 to Suppress the Keratinocyte's Innate Immune Response
Rezaul Karim, Bart Tummers, Craig Meyers, et al.
PLoS Pathogens (2013) Vol. 9, Iss. 5, pp. e1003384-e1003384
Open Access | Times Cited: 171

Human papillomavirus and oropharynx cancer: Biology, detection and clinical implications
Clint Allen, James S. Lewis, Samir K. El‐Mofty, et al.
The Laryngoscope (2010) Vol. 120, Iss. 9, pp. 1756-1772
Closed Access | Times Cited: 170

Estrogen and ERα: Culprits in cervical cancer?
Sang‐Hyuk Chung, Silvia Franceschi, Paul F. Lambert
Trends in Endocrinology and Metabolism (2010) Vol. 21, Iss. 8, pp. 504-511
Open Access | Times Cited: 166

Targeting Persistent Human Papillomavirus Infection
S. Shanmugasundaram, Jianxin You
Viruses (2017) Vol. 9, Iss. 8, pp. 229-229
Open Access | Times Cited: 162

Association between toll‐like receptor expression and human papillomavirus type 16 persistence
Ibrahim Daud, Mark E. Scott, Yifei Ma, et al.
International Journal of Cancer (2010) Vol. 128, Iss. 4, pp. 879-886
Open Access | Times Cited: 158

Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women
Katie E. Lichter, Danielle Krause, Jingwen Xu, et al.
Obstetrics and Gynecology (2020) Vol. 135, Iss. 5, pp. 1070-1083
Open Access | Times Cited: 72

Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis
Violante Di Donato, Giuseppe Caruso, Marco Petrillo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 410-410
Open Access | Times Cited: 62

HPV Vaccination after Primary Treatment of HPV-Related Disease across Different Organ Sites: A Multidisciplinary Comprehensive Review and Meta-Analysis
Violante Di Donato, Giuseppe Caruso, Giorgio Bogani, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 239-239
Open Access | Times Cited: 51

Correlation of Cellular Immunity With Human Papillomavirus 16 Status and Outcome in Patients With Advanced Oropharyngeal Cancer
Derrick Wansom, Emily Light, F. Worden, et al.
Archives of Otolaryngology - Head and Neck Surgery (2010) Vol. 136, Iss. 12, pp. 1267-1267
Open Access | Times Cited: 114

Development of therapeutic HPV vaccines
Cornelia L. Trimble, Ian H. Frazer
The Lancet Oncology (2009) Vol. 10, Iss. 10, pp. 975-980
Open Access | Times Cited: 102

Type-Specific Cervico-Vaginal Human Papillomavirus Infection Increases Risk of HIV Acquisition Independent of Other Sexually Transmitted Infections
Karen Smith‐McCune, Stephen Shiboski, Mike Chirenje, et al.
PLoS ONE (2010) Vol. 5, Iss. 4, pp. e10094-e10094
Open Access | Times Cited: 101

The human papillomavirus E7 oncoprotein as a regulator of transcription
William K. Songock, Seong‐Man Kim, Jason M. Bodily
Virus Research (2016) Vol. 231, pp. 56-75
Open Access | Times Cited: 82

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation
Bart Tummers, Renske Goedemans, Laetitia P.L. Pelascini, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 74

Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance
Matthew L. Scott, Brittany Woodby, Joseph Ulicny, et al.
Journal of Virology (2019) Vol. 94, Iss. 2
Open Access | Times Cited: 68

Association between human papillomavirus infection and prostate cancer: A global systematic review and meta‐analysis
Mohsen Moghoofei, Mohsen Keshavarz, Saied Ghorbani, et al.
Asia-Pacific Journal of Clinical Oncology (2019) Vol. 15, Iss. 5
Open Access | Times Cited: 58

Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta‐analysis
Dina Overgaard Eriksen, Pernille Tine Jensen, Jeppe Bennekou Schroll, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2022) Vol. 101, Iss. 6, pp. 597-607
Open Access | Times Cited: 29

Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
Karen S. Anderson, Jennifer S. Wong, Gypsyamber D’Souza, et al.
British Journal of Cancer (2011) Vol. 104, Iss. 12, pp. 1896-1905
Open Access | Times Cited: 70

Page 1 - Next Page

Scroll to top